• LAST PRICE
    0.2050
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.2000 / 0.2050
  • Day Range
    Low 0.2000
    High 0.2150
  • 52 Week Range
    Low 0.1210
    High 0.6000
  • Volume
    6,981
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.15
TimeVolumeGTHP
09:48 ET1100.2
10:32 ET3000.215
02:42 ET18700.203792
03:54 ET47000.205
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGTHP
Guided Therapeutics Inc
7.7M
-1.6x
---
United StatesHLTT
Healthtech Solutions Inc
7.1M
-1.0x
---
United StatesGCTK
GlucoTrack Inc
8.9M
-1.4x
---
United StatesSQL
SeqLL Inc
6.4M
-1.2x
---
United StatesAEMD
Aethlon Medical Inc
7.2M
-0.5x
---
United StatesRMED
Ra Medical Systems Inc
5.6M
0.0x
---
As of 2023-06-06

Company Information

Guided Therapeutics, Inc. is a medical technology company. The Company is focused on the development of medical devices. The Company develops prototypes and conducts limited clinical studies using its biophotonic technology for the detection of esophageal cancer. Its primary focus is selling and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide an alternative to conventional tests for cervical cancer screening and detection. It is focused on two primary applications for LuViva: first, as a cancer screening tool and second, as a triage for various traditional screening.

Contact Information

Headquarters
Suite 300, 4955 Avalon Ridge PkwyNORCROSS, GA, United States 30071
Phone
770-242-8723
Fax
770-242-8639

Executives

Independent Chairman of the Board
Michael James
President, Chief Executive Officer, Director
Mark Faupel
Acting Chief Financial Officer
Gene Cartwright
Director
Richard Blumberg
Director
Alan Grujic

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$7.7M
Revenue (TTM)
$30.0K
Shares Outstanding
51.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.63
EPS
$-0.13
Book Value
$-0.06
P/E Ratio
-1.6x
Price/Sales (TTM)
255.1
Price/Cash Flow (TTM)
---
Operating Margin
-14,023.33%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.